Tagged with US

France Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps Region as well as the challenges posed by domestic and international competition.   Between 2007-2016, the number of biotech companies doubled in the Lyon region and there was a sharp increase…

USA Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES) and how it will improve access to medicines and restore healthy competition to the market.    American taxpayers, along with millions of patients, will benefit…

France Stéphane Roques, CEO of Medicen, the health care cluster for the Paris region, discusses his vision for Medicen and the changes he has made during his first few months in the tole. He highlights the need for domestic and European collaboration to be able to compete against clusters in the…

France David Kimelfeld, president of Lyon Métropole, speaks out about his plans for the region in terms of industrial innovation and sustainability, describing how Lyon’s historical roots would represent and enhance its future development.   Lyon has become recognized nationally and internationally as possessing all the requisite qualities to host high…

USA David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the healthcare market for 2018.     Following a decade high of VC invested in 2017, and on a record pace again in 2018, valuations continue to move higher across all stages within…

Innovation Buck Dossey, an expert in digital marketing and audience manager at Adobe, discusses consumer needs in healthcare and the importance of adopting a digital health strategy.  Joining the digital transformation race today means that many companies will have to transform to become digitally agile.  While the topic of digital transformation permeates…

Cyprus George Campanellas provides an overview of Invest Cyprus’ strategy for attracting foreign investment into Cyprus. He touches on sourcing interest from a wide range of sectors and highlights what makes Cyprus such an exciting and advantageous investment destination.   Diversifying our economy from traditional industries such as tourism and shipping,…

Cyprus With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with the island now on the road to economic recovery following the EUR ten billion IMF-ECB-EU troika bailout in 2013, an…

Cyprus In an exclusive interview, President Nicos Anastasiades outlines his public health priorities, the continuing importance of the pharmaceutical industry to Cyprus’s economy, and the nation’s attractiveness as an international investment destination. Ensuring our citizens’ good health is not negotiable. What are your main priorities and policies for public health for…

Regulation Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the United States, discusses the contradictory nature of Trump’s efforts to lower drug prices.    The President has forcefully pledged to provide relief to these patients and their families, but his own trade policy threatens…

Biotech Pfizer has teamed up with Bain Capital to launch Cerevel Therapeutics, a biopharmaceutical company based in Boston that will focus on developing treatments for a number of central nervous system (CNS) disorders. It has almost been a year since Pfizer announced that they were to cease R&D in new neuroscience…

USA After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research Foundation to support families of those suffering from the illness and to accelerate the path to better therapies. Here she discusses the importance of community for tackling rare…